Company Heart Test Laboratories, Inc.

Equities

HSCS

US42254E3027

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Heart Test Laboratories, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Monitoring Systems

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-17 EDT			5-day change	1st Jan Change
6.97 ^USD	-38.37%		-20.80%	-59.24%

04-24	HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	CI
03-26	HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	CI

Heart Test Laboratories, Inc., doing business as HeartSciences, is an artificial intelligence electrocardiogram (AI ECG) company. The Company is focused on using AI to transform ECG to save lives through earlier detection of heart disease. The Companyâs initial focus is on applying technology to extend the clinical indications for use of an electrocardiograph (ECG) device. Its first device, the MyoVista is an ECG that can be used in a range of clinical settings and provides diagnostic information to a qualified healthcare professional on cardiac dysfunction which has traditionally only been provided using cardiac imaging. In addition, MyoVista provides conventional ECG information. The Company focuses on marketing its device both domestically and internationally to various hospitals, clinics, and medical centers and manufacturing the devices using outsourced production facilities.

Number of employees: 12

USD in Million	2022	Weight	2023	Weight	Delta
Cardiovascular Diagnostic Technology 100.0 %	0	100.0 %	0	100.0 %	-64.17%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	-64.17%

Managers	Title	Age	Since
Andrew Simpson CEO	Chief Executive Officer	55	13-07-24
Danielle Watson DFI	Director of Finance/CFO	42	21-10-31
Aaron Peterson CTO	Chief Tech/Sci/R&D Officer	-	14-06-30
Mark Hilz COO	Chief Operating Officer	66	13-07-24

Members of the board	Title	Age	Since
Mark Hilz COO	Chief Operating Officer	66	13-07-24
David R. Wells BRD	Director/Board Member	61	22-12-27
Andrew Simpson CEO	Chief Executive Officer	55	13-07-24
Bruce Bent BRD	Director/Board Member	68	20-04-30
Brian Szymczak BRD	Director/Board Member	51	13-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	65,561,630	55,066,156 ( 83.99 %)	0	83.99 %

Name	Equities	%	Valuation
The Mount Sinai Hospital 7.405 %	4,854,853	7.405 %	485 485 $
John H. Matthews 6.059 %	3,972,549	6.059 %	397 255 $
Andrew Simpson 0.8217 %	538,748	0.8217 %	53 875 $
Mark Hilz 0.6796 %	445,562	0.6796 %	44 556 $
Front Range Ventures LLC 0.4397 %	288,247	0.4397 %	28 825 $
Virtu Financial LLC 0.3895 %	255,382	0.3895 %	25 538 $
Paul Buchanan 0.3772 %	247,327	0.3772 %	24 733 $
Lary Snodgrass 0.3703 %	242,762	0.3703 %	24 276 $
Vanguard Group, Inc. (Subfiler) 0.2922 %	191,541	0.2922 %	19 154 $
Tradition Wealth Management LLC 0.2753 %	180,465	0.2753 %	18 047 $

Name	Equities	%	Valuation
Armistice Capital LLC -	352,941	-	18 000 $
Clear Street LLC -	266,264	-	13 579 $
Citadel Securities GP LLC -	151,664	-	7 735 $
Virtu Financial LLC -	23,762	-	1 212 $
BofA Securities, Inc. -	88	-	4 $

Name	Equities	%	Valuation
Front Range Ventures LLC 31.99 %	148,213	31.99 %	14 821 $
Lary Snodgrass 6.312 %	29,240	6.312 %	2 924 $
Paul Buchanan 4.446 %	20,599	4.446 %	2 060 $
Andrew Simpson 1.320 %	6,117	1.320 %	612 $
Mark Hilz 0.4490 %	2,080	0.4490 %	208 $
Brian Szymczak 0.0863 %	400	0.0863 %	40 $

Heart Test Laboratories, Inc.

550 Reserve Street Suite 360

76092, Southlake

+682 237 7781

http://www.heartsciences.com

address Heart Test Laboratories, Inc.(HSCS)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.97 USD

Average target price

67.5 USD

Spread / Average Target

+868.44%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Monitoring Systems

	1st Jan change	Capi.
HEART TEST LABORATORIES, INC.	-59.24%	4.57M
IRHYTHM TECHNOLOGIES, INC.	-11.41%	2.95B
EKF DIAGNOSTICS HOLDINGS PLC	+4.27%	190M
MEDIANA CO.,LTD	-14.72%	84.22M
NEUROTECH INTERNATIONAL LIMITED	+13.04%	53.05M

Medical Monitoring Systems